Inicure

About

An experienced team in immunology and drug development.

Inicure AB was founded in 2024 in Gothenburg, Sweden, as a spinoff from Pronoxis AB. We develop patent-protected compounds supported by peer-reviewed science.

Portrait of Peter Olofsson-Sahl

Peter Olofsson-Sahl

CEO

Preclinical drug development and international project management. Founder of several innovative research companies.

Portrait of Sara Malcus

Sara Malcus

Chair Board of Directors

Business development and investment management, with extensive life science start-up executive and Board experience.

Portrait of Johan Bylund

Johan Bylund

CSO

Professor in Microbiology, focused on immunology and infections including targeting of immunological mechanisms.

Portrait of Felix Sanchez Klose

Felix Sanchez Klose

Researcher — Product Development

Immunology and infection biology combined with bio-engineering, method development and instrumentation.

Company

Legal entity
Inicure AB
Location
Gothenburg, Sweden
Founded
2024
Origin
Spinoff from Pronoxis AB